Skip to main content
Log in

Challenges in the Ethical Review of Research Involving Complementary and Integrative Medicine

  • Product Safety: Meeting Report
  • Published:
Therapeutic Innovation & Regulatory Science Aims and scope Submit manuscript

Abstract

Complementary and integrative medicine (CIM) involves using practices outside mainstream Western medicine, often derived from Eastern traditional medicine, and combining those practices with Western medicine. Conducting CIM research that is necessary to determine whether particular interventions are beneficial and safe will involve a set of ethical challenges. Institutional review boards (IRBs), also known as research ethics committees or research ethics boards, are responsible for determining that research studies involving human subjects appropriately address ethical and regulatory concerns inherent to the research. Like other research with human subjects, research involving CIM is subject to ethical review and ongoing oversight by an IRB. IRBs are often challenged by the review of CIM. These challenges include accounting for cultural differences and the interests of competing stakeholders. In this report, we describe these issues that were the focus of a workshop that was part of an international conference held in Seoul, Korea, on April 4, 2015.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. National Center for Complementary and Integrative Health. Complementary, alternative, or integrative health: what’s in a name? https://nccih.nih.gov/health/integrative-health.

  2. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med. 2005;11(1):42–49.

    PubMed  Google Scholar 

  3. Vogel JH, Bolling SF, Costello RB, et al. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol. 2005;46(1):184–221.

    Article  Google Scholar 

  4. Cassileth BR, Deng G. Complementary and alternative therapies for cancer. Oncologist. 2004;9(1):80–89.

    Article  Google Scholar 

  5. Sugarman J, Burk L. Physicians’ ethical obligations regarding alternative medicine. JAMA 1998; 280: 1623–1625.

    Article  CAS  Google Scholar 

  6. The medical case, trials of war criminals before the Nuremberg Military Tribunals under Control Council Law No. 10. United States v Karl Brandt et al. Washington, DC: US GPO, 1949.

  7. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Ferney-Voltaire, France: World Medical Association, 64th Annual Assembly, Fortaleza, Brazil, October 2013. http://www.wma.net/en/30publications/10policies/b3/.

  8. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. Washington, DC: US Department of Health, Education, and Welfare, 1979. http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html

    Google Scholar 

  9. World Health Organization. WHO Traditional Medicine Strategy: 2014–2023. Geneva: World Health Organization, 2013.

    Google Scholar 

  10. National Center for Complementary and Integrative Health website. https://nccih.nih.gov/.

  11. Protection of Human Subjects. 45 CFR 46. Revised January 15, 2009. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html

  12. IRB membership. Protection of Human Subjects. 45 CFR 46.107. Revised January 15, 2009. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.107

  13. Criteria for IRB approval of research. Protection of Human Subjects. 45 CFR 46.111. Revised January 15, 2009. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html#46.111

  14. Secretary’s Advisory Committee on Human Research Protections (SACHRP): Appendix B. http://www.hhs.gov/ohrp/sachrp/sachrpltrtohhssecapdb.html

  15. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355(9198):134–138.

    Article  CAS  Google Scholar 

  16. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286(2):208–216.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey A. Cooper MD, MMM.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooper, J.A., Borasky, D., Rosenfeld, S. et al. Challenges in the Ethical Review of Research Involving Complementary and Integrative Medicine. Ther Innov Regul Sci 50, 337–341 (2016). https://doi.org/10.1177/2168479015620246

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/2168479015620246

Keywords

Navigation